Mn(II) Optimized Sono/Chemodynamic Effect of Porphyrin‐Metal–Organic Framework Nanosheets for MRI‐Guided Colon Cancer Therapy and Metastasis Suppression
Small · 2024
DOI: 10.1002/smll.202306364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Lifeng Hang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Medical Imaging, Guangzhou Key Laboratory of Molecular Functional Imaging and Artificial Intelligence for Major Brain Diseases, Gua…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Colonic Neoplasms, Porphyrins, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Projects in Guangzhou, Medical Scientific Research Foundation of Guangdong Province of China.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) offers a remarkable non‐invasive ultrasound (US) treatment by activating sonosensitizer and generating reactive oxygen species (ROS) to inhibit tumor growth. The development of multifunctional, biocompatible, and highly effective sonosensitizers remains a current priority for SDT. Herein, the first report that Mn(II) ions chelated Gd‐TCPP (GMT) nanosheets (NSs) are synthesized via a simple reflux method and encapsulated with pluronic F‐127 to form novel sonosensitizers (GMTF). The GMTF NSs produce a high yield of ROS under US irradiation due to the decreased highest occupied molecular orbital−lowest unoccupied molecular orbital gap energy (2.7–1.28 eV). Moreover, Mn(II) ions endow GMTF with a fascinating Fenton‐like activity to produce hydroxyl radicals in support of chemodynamic therapy (CDT). It is also effectively used in magnetic resonance imaging (MRI) with high relaxation rate ( r 1 : 4.401 mM −1 s −1 ) to track the accumulation of NSs in tumors. In vivo results indicate that the SDT and CDT in combination with programmed cell death protein 1 antibody (anti‐PD‐1) show effective metastasis prevention effects, and 70% of the mice in the GMTF + US + anti‐PD‐1 group survived for 60 days. In conclusion, this study develops a sonosensitizer with promising potential for utilizing both MRI‐guided SDT and CDT strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Medical Imaging, Guangzhou Key Laboratory of Molecular Functional Imaging and Artificial Intelligence for Major Brain Diseases, Guangdong Second Provincial General Hospital, Guangzhou, 518037, P. R. Ch…
- Department of Neurosurgery, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, P. R. China.
- Interventional Radiology Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, P. R. China.
- School of Materials and Energy, Guangdong University of Technology, Guangzhou, 510006, P. R. China.
ORCID-Profile: Guihua Jiang
Förderung
- National Natural Science Foundation of China
- Science and Technology Projects in Guangzhou
- Medical Scientific Research Foundation of Guangdong Province of China
Zitieren
APA
Hang, L., Li, M., Zhang, Y., Li, W., Fang, L., Chen, Y., Zhou, C., Qu, H., Shao, L., & Jiang, G. (2024). Mn(II) Optimized Sono/Chemodynamic Effect of Porphyrin‐Metal–Organic Framework Nanosheets for MRI‐Guided Colon Cancer Therapy and Metastasis Suppression. Small. https://doi.org/10.1002/smll.202306364
Vancouver
Hang L, Li M, Zhang Y, Li W, Fang L, Chen Y, et al. Mn(II) Optimized Sono/Chemodynamic Effect of Porphyrin‐Metal–Organic Framework Nanosheets for MRI‐Guided Colon Cancer Therapy and Metastasis Suppression. Small. 2024. doi:10.1002/smll.202306364
BibTeX
@article{Hang2024,
author = {Hang, Lifeng and Li, Meng and Zhang, Yuxuan and Li, Wuming and Fang, Laiping and Chen, Yiyu and Zhou, Chunze and Qu, Hong and Shao, Lianyi and Jiang, Guihua},
title = {Mn(II) Optimized Sono/Chemodynamic Effect of Porphyrin‐Metal–Organic Framework Nanosheets for MRI‐Guided Colon Cancer Therapy and Metastasis Suppression},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202306364}
}
EUVIMED